Loading news...
Cibc World Market Inc. boosted its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 50.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,795 shares of the medical research company's stock after buying an additional
Investors need to pay close attention to IQVIA stock based on the movements in the options market lately.
Oakmark Global All Cap Strategy portfolio's return was 4.99% (net) for the reporting period vs. MSCI World Index that returned 3.12% for the same period. Contributors in the quarter were DSV, IQVIA Holdings and Samsung Electronics Pfd. Detractors in the quarter were Alibaba Group, CNH Industrial and Dassault Systemes.
Compagnie Lombard Odier SCmA lessened its stake in shares of IQVIA Holdings Inc. (NYSE: IQV) by 15.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,057 shares of the medical research company's stock after selling 17,275 shares during the period. Compagnie Lombard Odier
OPTIMAS CAPITAL Ltd purchased a new stake in shares of IQVIA Holdings Inc. (NYSE: IQV) in the third quarter, according to its most recent filing with the SEC. The firm purchased 21,100 shares of the medical research company's stock, valued at approximately $4,008,000. IQVIA accounts for about 2.5% of OPTIMAS CAPITAL Ltd's portfolio,
IQVIA (NYSE: IQV) executives said the company closed 2025 with a "strong" fourth quarter as revenue came in above the high end of management's guidance range and clinical demand indicators improved as the year progressed. On the company's fourth-quarter earnings call, management also introduced a simplified reporting structure for 2026, highlighted recent acquisitions and partnerships, and
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IQVIA (NYSE: IQV - Get Free Report) and Xcorporeal (OTCMKTS:XCRP - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Insider and Institutional Ownership 89.6% of IQVIA shares are held
Full Year Revenue Growth: 6%.Adjusted Diluted EPS Growth: 7%.Free Cash Flow: $2.1 billion, approximately 100% of adjusted net income.Fourth Quarter Revenue: $4
IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript
IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.
IQVIA Holdings (IQV) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.4 per share. This compares to earnings of $3.12 per share a year ago.
Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong fourth-quarter results underscored improving demand from pharmaceutical clients.
Shares of IQVIA Holdings Inc. (NYSE: IQV - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eighteen brokerages that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and two have given a strong buy recommendation
Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
IQV is set to report fourth-quarter 2025 earnings results on Feb. 5, with revenues expected to rally 7.2% y/y to $4.2B and EPS to rise 9% on segment growth.
Besides Wall Street's top-and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
New York State Common Retirement Fund trimmed its stake in IQVIA Holdings Inc. (NYSE: IQV) by 5.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,080 shares of the medical research company's stock after selling 5,900 shares during the period.
Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech, leaving the sector feeling like a missed opportunity.